313 related articles for article (PubMed ID: 29445028)
1. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
[TBL] [Abstract][Full Text] [Related]
2. Estimates of Overall Survival in Patients With Cancer Receiving Different Treatment Regimens: Emulating Hypothetical Target Trials in the Surveillance, Epidemiology, and End Results (SEER)-Medicare Linked Database.
Petito LC; García-Albéniz X; Logan RW; Howlader N; Mariotto AB; Dahabreh IJ; Hernán MA
JAMA Netw Open; 2020 Mar; 3(3):e200452. PubMed ID: 32134464
[TBL] [Abstract][Full Text] [Related]
3. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
4. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
6. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.
Smith GL; Smith BD; Buchholz TA; Liao Z; Jeter M; Swisher SG; Hofstetter WL; Ajani JA; McAleer MF; Komaki R; Cox JD
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):482-9. PubMed ID: 19289262
[TBL] [Abstract][Full Text] [Related]
7. EUS and survival in patients with pancreatic cancer: a population-based study.
Ngamruengphong S; Li F; Zhou Y; Chak A; Cooper GS; Das A
Gastrointest Endosc; 2010 Jul; 72(1):78-83, 83.e1-2. PubMed ID: 20620274
[TBL] [Abstract][Full Text] [Related]
8. Treatment, survival, and costs of oropharyngeal cancer care in the elderly.
Gourin CG; Fakhry C; Quon H; Kang H; Kiess AP; Herbert RJ; Eisele DW; Frick KD
Laryngoscope; 2018 May; 128(5):1103-1112. PubMed ID: 28988469
[TBL] [Abstract][Full Text] [Related]
9. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.
Krzyzanowska MK; Weeks JC; Earle CC
J Clin Oncol; 2003 Sep; 21(18):3409-14. PubMed ID: 12972517
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
11. Treatment patterns and comparative effectiveness in elderly diffuse large B-cell lymphoma patients: a surveillance, epidemiology, and end results-medicare analysis.
Hamlin PA; Satram-Hoang S; Reyes C; Hoang KQ; Guduru SR; Skettino S
Oncologist; 2014 Dec; 19(12):1249-57. PubMed ID: 25342313
[TBL] [Abstract][Full Text] [Related]
12. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.
Enewold L; Harlan LC; Tucker T; McKenzie S
J Gastrointest Cancer; 2015 Mar; 46(1):9-20. PubMed ID: 25403828
[TBL] [Abstract][Full Text] [Related]
14. Acute Leukemia of Ambiguous Lineage in Elderly Patients - Analysis of Survival Using Surveillance Epidemiology and End Results-Medicare Database.
Guru Murthy GS; Dhakal I; Lee JY; Mehta P
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):100-107. PubMed ID: 27998706
[TBL] [Abstract][Full Text] [Related]
15. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
17. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.
Parmar AD; Vargas GM; Tamirisa NP; Sheffield KM; Riall TS
Surgery; 2014 Aug; 156(2):280-9. PubMed ID: 24851723
[TBL] [Abstract][Full Text] [Related]
18. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
[TBL] [Abstract][Full Text] [Related]
19. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data.
Hanna NN; Onukwugha E; Choti MA; Davidoff AJ; Zuckerman IH; Hsu VD; Mullins CD
Colorectal Dis; 2012 Jan; 14(1):48-55. PubMed ID: 21689262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
